National TBI survey reveals continuing reliance on extended SSD and growing adoption of IMRT

Seven Saudi TBI centers reported approximately 386 annual cases, with conventional extended-SSD techniques predominant and IMRT adoption expanding.

KEY POINTS

  • This national cross-sectional survey collected responses from all seven centers providing total body irradiation in Saudi Arabia during May–June 2026. Multidisciplinary respondents included radiation oncologists, medical physicists, and radiation therapists, with one center submitting separate responses for conventional and VMAT workflows.
  • The seven institutions reported an estimated 386 TBI treatments annually, with center-level caseloads ranging from 12 to 120 patients per year. Programs had originally been commissioned between 1980 and 2020, reflecting considerable variation in infrastructure, experience, and treatment capacity.
  • Fractionated TBI with 10–12 Gy in six twice-daily fractions was the predominant high-dose regimen for adults and children. All centers maintained a minimum six-hour interval between fractions, while lower-dose schedules such as 2–4 Gy in one or two fractions were also used for selected transplantation indications.
  • Conventional extended source-to-surface distance (SSD) irradiation remained in use at six centers, usually with opposed beams and prescription to the umbilicus. IMRT-based delivery, including VMAT and Tomotherapy, was available in three centers, with two institutions operating both conventional and more advanced approaches.
  • Modern IMRT-based TBI workflows used CT simulation, volumetric planning, and explicit OAR constraints. Reported objectives included mean lung dose below 8 Gy, kidney mean dose limits ranging from below 8 to 10 Gy, and lens maximum-dose limits of 8–12 Gy, depending on the institution and treatment technique.
  • Planning and QA practices were heterogeneous. Conventional treatment planning used spreadsheets, predefined templates, or treatment planning systems, whereas IMRT-TBI relied more heavily on TPS-based optimization. All seven centers performed in-vivo dosimetry, commonly using 3–8 detectors at anatomical locations including the head, lungs, umbilicus, and pelvis.
  • Three centers planned initial implementation of IMRT-TBI within three years. Improved OAR dose control was the leading motivation, while linac availability, staff training, and treatment workflow were major barriers. The survey describes institutional practices rather than patient-level dosimetry or clinical outcomes, so it cannot establish superiority of any delivery technique.

CLINICAL TAKEAWAY

This national survey illustrates the continuing transition from extended-SSD total body irradiation toward image-guided, intensity-modulated approaches with more explicit organ-at-risk dose management. Its main value is as a benchmark for technical standardization and service development, particularly regarding dose constraints, in-vivo dosimetry, staff training, and access to modern TBI techniques.

SOURCE

Frontiers in Oncology

Browse more research Suggest a correction